Late onset hemorrhagic disease of newborn is characterized by all of the following features except?
## Core Concept
Late onset hemorrhagic disease of the newborn (HDN) typically occurs after the first 24 hours of life, often around 2-14 days postpartum. It is primarily associated with vitamin K deficiency, which is crucial for the gamma-carboxylation of clotting factors II, VII, IX, and X. This condition highlights the importance of vitamin K administration at birth to prevent early and late forms of vitamin K deficiency bleeding.
## Why the Correct Answer is Right
The correct answer cannot be evaluated without the specific options provided. However, late onset HDN is generally characterized by features such as:
- Prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT)
- Low levels of vitamin K-dependent clotting factors
- Bleeding manifestations that can range from mild to severe
- Often associated with breastfeeding and lack of vitamin K prophylaxis at birth
## Why Each Wrong Option is Incorrect
Without specific details on options A, B, C, and D, a direct evaluation cannot be made. However, we can infer that incorrect options might include statements that:
- **Option A:** Incorrectly attribute late onset HDN to a cause other than vitamin K deficiency (e.g., prematurity, infection)
- **Option B:** Suggest a feature not typically associated with late onset HDN (e.g., thrombocytosis, normal PT/aPTT)
- **Option C:** Describe a condition or timing not aligned with late onset HDN (e.g., symptoms present at birth, associated with factor VIII deficiency)
- **Option D:** Imply a treatment or prevention method not standard for late onset HDN (e.g., immediate surgical intervention, use of fresh frozen plasma without vitamin K)
## Clinical Pearl / High-Yield Fact
A key point to remember is that **breastfed infants are at higher risk for late vitamin K deficiency bleeding**, and these infants may benefit from vitamin K supplementation. Additionally, mothers on certain medications (e.g., anticonvulsants, anticoagulants) can have infants at higher risk due to the effects on vitamin K metabolism.
## Correct Answer: D.